Navigation Links
REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body
Date:2/4/2008

, compared with zero patients in the placebo group. Overall, the AEs were consistent with those seen in previous trials. Please see "Important Safety Information" below.

About Psoriasis

Psoriasis is a chronic, immune-mediated disorder, which results from inflammation in the skin and overproduction of skin cells that accumulate on the surface causing red, scaly plaques that may itch and bleed. This chronic inflammation is driven in part by tumor necrosis factor alpha, or TNF-alpha, a cytokine involved in the body's normal immune response. TNF-alpha is found at increased levels in psoriatic plaques and plays a crucial part in their formation and continued existence. It is estimated that 2 percent of the U.S. population has psoriasis, and about 30 percent of people with psoriasis have cases that are considered moderate to severe.

About REMICADE

REMICADE is the global market leader among anti-tumor necrosis factor alpha (TNF-alpha) therapies and is the only anti-TNF-alpha treatment approved in three different therapeutic areas: gastroenterology, rheumatology and dermatology. REMICADE has demonstrated broad clinical utility in Crohn's disease (CD), rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), ulcerative colitis (UC), pediatric Crohn's disease (PCD) and psoriasis (PsO). The safety and efficacy of REMICADE have been well established in clinical trials over the past 14 years and with more than one million patients treated worldwide through commercial experience.

In the U.S., REMICADE is approved for the following indications:

-- Reducing signs and symptoms, inhibiting the progression of structural

damage and improving physical function in patients with moderately to

severely active RA, when administered in combination with methotrexate.

-- Reducing signs and symptoms in patients with active AS.

-- Reducing signs and symptoms and inducing and maintaining clini
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Observational Data Show Transfusion Patterns in Chemotherapy-Induced Anemia Patients Receiving Erythropoiesis-Stimulating Agents
2. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
3. JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients
4. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
5. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
6. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
8. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
10. Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkins Lymphoma
11. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... , May 6, 2015 In ... malaria and tuberculosis combined[1]. Approximately 40 percent of cancer cases ... the right treatment[3]. Together with Elekta, ministries of health in ... their radiation therapy infrastructures and save lives. More ... from radiation therapy[4] during the course of their disease, either ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ... of the "Asia-Pacific Internal Trauma Fixation Devices ... and Forecast To 2019" report to their ... Devices market is estimated to grow at a ... such as technological advancement, rising incidences of road ...
(Date:5/6/2015)... , May 6, 2015   GenSpera, Inc. ... Compositions" has entered the national phase application process in 17 ... Japan , China , ... States . When awarded, the resulting patent application will ... its entire platform technology, including its lead drug candidate, mipsagargin, ...
Breaking Medicine Technology:Elekta to bring cancer treatment to millions in Africa 2Elekta to bring cancer treatment to millions in Africa 3Elekta to bring cancer treatment to millions in Africa 4Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
(Date:5/6/2015)... 2015 Edvance360 LMS-SN , a ... won the Software & Information Industry Association's (SIIA) ... "Best Postsecondary Learning Management Solution" category. Edvance360 LMS-SN ... finalists for this award seven years running, continued proof ... in the industry. , "The honor of being ...
(Date:5/6/2015)... A quality built chicken coop condo with a wheel kit is ... chickens on a pasture. By installing a wheel kit on ... chicken tractor that stands up to being moved around the pasture ... able to flex to uneven ground without losing its shape. ... and it will help provide the chickens with fresh foraging plots ...
(Date:5/6/2015)... Chesapeake, Va. (PRWEB) May 06, 2015 ... hospital in the state of Virginia to acquire ... Vinci® surgical robot. The system upgrade includes enhanced ... many minimally invasive procedures across a wide spectrum ... surgical options, reduced pain and quicker recovery times. ...
(Date:5/6/2015)... 06, 2015 The Beryl Institute announces ... of Patient Experience Journal (PXJ), an international, open access, ... understanding and improving patient experience. The second volume of ... conversation globally, helps align the voices engaged and provides ... Published in association with The Beryl Institute, Volume 2, ...
(Date:5/6/2015)... Denver, Colorado (PRWEB) May 06, 2015 ... own success? , Next month the Centennial State will ... legal, recreational cannabis sales to adults. And while Colorado’s ... rapid growth during that time, it’s also facing some ... the state are currently facing shortages, especially in the ...
Breaking Medicine News(10 mins):Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Chicken Coop Condo Launches the Chicken Tractor 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3
... for the Prudent Use of Antibiotics (APUA) strongly opposes ... Publix, and other large chains, to provide free prescribed ... but they will actually lead to increased costs in ... While the public,s need for affordable healthcare is ...
... organizations offers five action steps to improve responseWASHINGTON, Jan. ... allow the delivery of food and medical supplies to ... still lack access to food, clean water and medical ... region see this arrangement to allow sporadic delivery of ...
... St. Jude study could shape new treatments for ... St. Jude Children,s Research Hospital have demonstrated a ... They found that the antibiotics clindamycin and azithromycin, ... are more effective than a standard first-line treatment ...
... Mall of AmericaMINNEAPOLIS, Jan. 8 , WHO: Dance ... the 3rd annual Dance, ... event will be emceed by Tom Butler, Fox 9 TV ... raise money through pledges to benefit Camp, ...
... Jan. 8 /PRNewswire-Asia/ -- Chindex International, Inc.,(Nasdaq: ... American,provider of Western healthcare products and services in the ... attend the 2009 UBS Greater,China Conference, to be held ... The 2009 UBS Greater China Conference ...
... and Jason Brown, Ph.D. Promoted to Vice PresidentMINNEAPOLIS, SAN ... & Partners, a health care venture capital firm that ... announced the promotion of three members of its investment ... Christine Siu and Jason Brown have been promoted ...
Cached Medicine News:Health News:Antibiotics as Loss Leaders? 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 2Health News:Temporary Cease Fires Not Enough for Humanitarian Aid Groups Working in Gaza 3Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:Dance With Courage to Benefit Camp Courage 2Health News:Chindex International Inc. Announces Participation in the 2009 UBS Greater China Conference 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2
... Rigid plastic. Convenient. Single use. Kit comprises: 1 ... 2 Child; Miller 3 Medium Ad.; 1 Mac 2 ... Large Ad. 1 Chrome Handle, Standard, 1 Nylon Carrying ... sturdy yet lightweight way to take your disposable laryngoscopes ...
... Lamp supplied with blade. Oxygen port. ... on any standard/conventional handle allowing you ... without the potential confusion from different ... offer an easy and cost effective ...
... disposable blades are an economical option ... labor by requiring no sterilization, disinfecting, ... disposable blades help eliminate cross-contamination., ... concern for possible crosscontamination from AIDS, ...
... Medical's Articulating Tip Laryngoscopes are ... the Industry. The articulating tip ... providing an improved view of ... Fiber Optic styles. We guarantee ...
Medicine Products: